HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High doses of TGF-β potently suppress type I collagen via the transcription factor CUX1.

Abstract
Transforming growth factor-β (TGF-β) is an inducer of type I collagen, and uncontrolled collagen production leads to tissue scarring and organ failure. Here we hypothesize that uncovering a molecular mechanism that enables us to switch off type I collagen may prove beneficial in treating fibrosis. For the first time, to our knowledge, we provide evidence that CUX1 acts as a negative regulator of TGF-β and potent inhibitor of type I collagen transcription. We show that CUX1, a CCAAT displacement protein, is associated with reduced expression of type I collagen both in vivo and in vitro. We show that enhancing the expression of CUX1 results in effective suppression of type I collagen. We demonstrate that the mechanism by which CUX1 suppresses type I collagen is through interfering with gene transcription. In addition, using an in vivo murine model of aristolochic acid (AA)-induced interstitial fibrosis and human AA nephropathy, we observe that CUX1 expression was significantly reduced in fibrotic tissue when compared to control samples. Moreover, silencing of CUX1 in fibroblasts from kidneys of patients with renal fibrosis resulted in increased type I collagen expression. Furthermore, the abnormal CUX1 expression was restored by addition of TGF-β via the p38 mitogen-activated protein kinase pathway. Collectively, our study demonstrates that modifications of CUX1 expression lead to aberrant expression of type I collagen, which may provide a molecular basis for fibrogenesis.
AuthorsMaria Fragiadaki, Tetsurou Ikeda, Abigail Witherden, Roger M Mason, David Abraham, George Bou-Gharios
JournalMolecular biology of the cell (Mol Biol Cell) Vol. 22 Issue 11 Pg. 1836-44 (Jun 01 2011) ISSN: 1939-4586 [Electronic] United States
PMID21471005 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Aristolochic Acids
  • CUX1 protein, human
  • Collagen Type I
  • Homeodomain Proteins
  • Nuclear Proteins
  • Repressor Proteins
  • SMAD3 protein, human
  • SMAD7 protein, human
  • Smad3 Protein
  • Smad7 Protein
  • Transcription Factors
  • Transforming Growth Factor beta
  • p38 Mitogen-Activated Protein Kinases
Topics
  • Animals
  • Aristolochic Acids
  • Cells, Cultured
  • Collagen Type I (antagonists & inhibitors, genetics)
  • Dose-Response Relationship, Drug
  • Feedback, Physiological
  • Fibrosis (drug therapy, prevention & control)
  • Gene Expression Regulation (drug effects)
  • Homeodomain Proteins (metabolism)
  • Humans
  • Kidney (pathology)
  • Kidney Diseases (chemically induced)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Nuclear Proteins (metabolism)
  • Promoter Regions, Genetic
  • Repressor Proteins (metabolism)
  • Smad3 Protein (metabolism)
  • Smad7 Protein
  • Transcription Factors
  • Transcription, Genetic
  • Transforming Growth Factor beta (pharmacology)
  • p38 Mitogen-Activated Protein Kinases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: